XML 240 R69.htm IDEA: XBRL DOCUMENT v3.24.2
Stock-based and Other Incentive Compensation - Stock Appreciation Rights Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Cash-settled awards      
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares)   3,452,120  
CSARs converted to SSARs / SSARs converted from CSARs (in shares) (1,978,761)    
Exercised (in shares) (863,648)    
Cancelled (in shares) (470,992)    
Forfeited (in shares) (19,815)    
Outstanding, ending balance (in shares) 118,904 118,904 3,452,120
Weighted Average Exercise Price      
Shares outstanding, Weighted average grant price, beginning balance (in dollars per share)     $ 18.77
CSARs converted to SSARs / SSARs converted from CSARs (in dollars per share) $ 21.12    
Exercised (in dollars per share) 7.46    
Cancelled (in dollars per share) 30.06    
Forfeited (in dollars per share) 29.10    
Shares outstanding, Weighted average grant price, ending balance (in dollars per share) $ 15.47 $ 15.47  
Shares outstanding, Weighted average remaining contractual life   1 year 3 months 14 days 1 year 8 months 19 days
Shares outstanding, Aggregate intrinsic value $ 3 $ 3 $ 37
Exercisable (in shares) 104,618 104,618  
Exercisable (in dollars per share) $ 13.63 $ 13.63  
Exercisable, Weighted average remaining contractual life   1 year  
Exercisable, Aggregate intrinsic value $ 3 $ 3  
Stock-settled stock appreciation rights      
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares)   0  
CSARs converted to SSARs / SSARs converted from CSARs (in shares) 1,978,761    
Exercised (in shares) (15,806)    
Forfeited (in shares) (6,932)    
Outstanding, ending balance (in shares) 1,956,023 1,956,023 0
Weighted Average Exercise Price      
CSARs converted to SSARs / SSARs converted from CSARs (in dollars per share) $ 21.12    
Exercised (in dollars per share) 13.02    
Forfeited (in dollars per share) 29.16    
Shares outstanding, Weighted average grant price, ending balance (in dollars per share) $ 21.15 $ 21.15  
Shares outstanding, Weighted average remaining contractual life   2 years 2 months 12 days  
Shares outstanding, Aggregate intrinsic value $ 27 $ 27  
Exercisable (in shares) 969,451 969,451  
Exercisable (in dollars per share) $ 13.07 $ 13.07  
Exercisable, Weighted average remaining contractual life   1 year 25 days  
Exercisable, Aggregate intrinsic value $ 21 $ 21